Biagio Ricciuti, Thoracic Medical Oncologist at Dana-Farber Cancer, shared a post on LinkedIn:
“Thoughtful and inspiring first day at RomeLung26. Grateful for the opportunity to co-chair this year’s International Summit on Lung Cancer alongside Federico Cappuzzo, Lorenza Landi, Rosario Garcia Campelo w/ an outstanding faculty and so many friends and colleagues from around the world.
Today’s discussions highlighted the rapid evolution of early-stage NSCLC, from perioperative and neoadjuvant strategies to biomarker-driven treatment selection and the expanding role of targeted therapeutics in metastatic lung cancer.”
Other Articles Featuring Biagio Ricciuti On OncoDaily.
